{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:36:14Z","timestamp":1768566974588,"version":"3.49.0"},"posted":{"date-parts":[[2024,6,12]]},"group-title":"Health Policy","reference-count":36,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,10,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Despite HPV vaccines\u2019 availability for over a decade, coverage across the US varies. While some states have tried to increase HPV vaccination coverage, most model-based analyses focus on national impacts. We evaluated hypothetical changes in HPV vaccination coverage at the national and state levels for California, New York, and Texas using a mathematical model.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We developed a new mathematical model of HPV transmission and cervical cancer, creating US and state-level models, incorporating country- and state-specific vaccination coverage and cervical cancer incidence and mortality. We quantified the national and state-level impact of increasing HPV vaccination coverage to 80% by 2025 or 2030 on cervical cancer outcomes and the time to elimination defined as &lt;4 per 100k women.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Increasing vaccination coverage to 80% in Texas over ten years could reduce cervical cancer incidence by 50.9% (95% credible interval [CrI]:46.6-56.1%) by 2100, from 1.58 (CrI:1.19-2.09) to 0.78 (CrI:0.57-1.02) per 100,000 women. Similarly, New York could see a 27.3% (CrI:23.9-31.5%) reduction, from 1.43 (CrI:0.93-2.07) to 1.04 (Crl:0.66-1.53) per 100,000 women, and California a 24.4% (CrI:20.0-30.0%) reduction, from 1.01 (Crl:0.66-1.44) to 0.76 (Crl:0.50-1.09) per 100,000 women. Achieving 80% coverage in five years will provide slightly larger and sooner reductions. If the vaccination coverage levels in 2019 continue, cervical cancer elimination could occur nationally by 2051 (Crl:2034-2064), but state timelines may vary by decades.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Targeting an HPV vaccination coverage of 80% by 2030 will disproportionately benefit states with low coverage and higher cervical cancer incidence. Geographically focused analyses can better inform priorities.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.06.11.24308795","type":"posted-content","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T11:50:14Z","timestamp":1718193014000},"source":"Crossref","is-referenced-by-count":0,"title":["State-level disparities in cervical cancer prevention and outcomes in the U.S.: A modeling study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-1172","authenticated-orcid":false,"given":"Fernando","family":"Alarid-Escudero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4853-2922","authenticated-orcid":false,"given":"Valeria","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-3432","authenticated-orcid":false,"given":"Marina","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-377X","authenticated-orcid":false,"given":"Caleb W.","family":"Easterly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-6618","authenticated-orcid":false,"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-0452","authenticated-orcid":false,"given":"Inge M.C.M.","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1793-6003","authenticated-orcid":false,"given":"Ruanne V.","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-9166","authenticated-orcid":false,"given":"Shalini","family":"Kulasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024102105250510000_2024.06.11.24308795v2.1","unstructured":"International Agency for Research on Cancer (IARC). Cervical Cancer Screening. Vol 18.; 2022. https:\/\/publications.iarc.fr\/604"},{"key":"2024102105250510000_2024.06.11.24308795v2.2","doi-asserted-by":"publisher","DOI":"10.2222\/jsv.56.219"},{"key":"2024102105250510000_2024.06.11.24308795v2.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003534"},{"key":"2024102105250510000_2024.06.11.24308795v2.4","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30006-2"},{"key":"2024102105250510000_2024.06.11.24308795v2.5","unstructured":"World Health Organization. Cervical Cancer Elimination Initiative. WHO. 2023. Accessed February 28, 2023. https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative"},{"key":"2024102105250510000_2024.06.11.24308795v2.6","unstructured":"World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem.; 2020. https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative"},{"key":"2024102105250510000_2024.06.11.24308795v2.7","unstructured":"Office of Disease Prevention and Health Promotion. Increase the proportion of adolescents who get recommended doses of the HPV vaccine \u2014 IID-08 - Healthy People 2030 | health.gov. Healthy People 2030. 2023. Accessed February 28, 2023. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/vaccination\/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08"},{"key":"2024102105250510000_2024.06.11.24308795v2.8","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1512453"},{"key":"2024102105250510000_2024.06.11.24308795v2.9","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-21-0307"},{"key":"2024102105250510000_2024.06.11.24308795v2.10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-012765"},{"key":"2024102105250510000_2024.06.11.24308795v2.11","doi-asserted-by":"crossref","unstructured":"Pingali C , Yankey D , Elam-Evans LD , et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13\u201317 Years \u2014 United States, 2020. 2021;70(35).","DOI":"10.15585\/mmwr.mm7035a1"},{"key":"2024102105250510000_2024.06.11.24308795v2.12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7135a1"},{"key":"2024102105250510000_2024.06.11.24308795v2.13","doi-asserted-by":"crossref","unstructured":"Pingali C , Yankey D , Elam-Evans LD , et al. Vaccination Coverage Among Adolescents Aged 13\u2013 17 Years \u2014 National Immunization Survey\u2013Teen, United States, 2022. 2023;72(34).","DOI":"10.15585\/mmwr.mm7234a3"},{"key":"2024102105250510000_2024.06.11.24308795v2.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.12.064"},{"key":"2024102105250510000_2024.06.11.24308795v2.15","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004149"},{"key":"2024102105250510000_2024.06.11.24308795v2.16","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkac053"},{"key":"2024102105250510000_2024.06.11.24308795v2.17","unstructured":"United States Census Bureau. U.S. Census Bureau QuickFacts: New York; United States; California; Texas. QuickFacts. Accessed October 10, 2024. https:\/\/www.census.gov\/quickfacts\/fact\/table\/NY,US,CA,TX\/PST045223"},{"key":"2024102105250510000_2024.06.11.24308795v2.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.058"},{"key":"2024102105250510000_2024.06.11.24308795v2.19","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X16686559"},{"key":"2024102105250510000_2024.06.11.24308795v2.20","unstructured":"University of California, Berkeley. United States Mortality DataBase. United States Mortality DataBase. 2023. Accessed September 1, 2019. https:\/\/usa.mortality.org\/"},{"key":"2024102105250510000_2024.06.11.24308795v2.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515528113"},{"key":"2024102105250510000_2024.06.11.24308795v2.22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27608"},{"key":"2024102105250510000_2024.06.11.24308795v2.23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv086"},{"key":"2024102105250510000_2024.06.11.24308795v2.24","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0299"},{"key":"2024102105250510000_2024.06.11.24308795v2.25","unstructured":"The Centers for Disease Control and Prevention (CDC). TeenVaxView. TeenVaxView | Home | CDC. 2023. Accessed August 18, 2023. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/teenvaxview\/index.html"},{"key":"2024102105250510000_2024.06.11.24308795v2.26","unstructured":"The Centers for Disease Control and Prevention (CDC). BRFSS Prevalence & Trends Data. BRFSS Prevalence & Trends Data. 2023. Accessed August 18, 2023. https:\/\/www.cdc.gov\/brfss\/brfssprevalence\/index.html"},{"key":"2024102105250510000_2024.06.11.24308795v2.27","doi-asserted-by":"publisher","DOI":"10.1097\/ede.0000000000001236"},{"key":"2024102105250510000_2024.06.11.24308795v2.28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.780917"},{"key":"2024102105250510000_2024.06.11.24308795v2.29","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780190880743.003.0016"},{"key":"2024102105250510000_2024.06.11.24308795v2.30","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(16)30001-9"},{"key":"2024102105250510000_2024.06.11.24308795v2.31","unstructured":"National Cancer Institute. SEER*Explorer. Accessed September 17, 2023. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=1&data_type=1&graph_type=2&compareBy=sex&chk_sex_3=3&chk_sex_2=2&rate_type=2&race=1&age_range=1&hdn_stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2#resultsRegion0"},{"key":"2024102105250510000_2024.06.11.24308795v2.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.003"},{"key":"2024102105250510000_2024.06.11.24308795v2.33","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1981842"},{"key":"2024102105250510000_2024.06.11.24308795v2.34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.24502"},{"key":"2024102105250510000_2024.06.11.24308795v2.35","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz227"},{"key":"2024102105250510000_2024.06.11.24308795v2.36","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X20924007"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.06.11.24308795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:03:00Z","timestamp":1768507380000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.06.11.24308795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1101\/2024.06.11.24308795","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1093\/jnci\/djae298","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,6,12]]},"subtype":"preprint"}}